Pharmaceuticals & Biologics

Our attorneys prepare and prosecute patent applications in the United States and worldwide to protect clients’ complex biologic and pharmaceutical innovations. These attorneys rely on their strong life science backgrounds and legal skills to protect clients’ complex technologies and innovations. The group has represented some of the industry’s biggest names.

Our services include managing global patent portfolios, guiding clients in their research efforts and working closely with inventor-scientists to develop valuable portfolios. We are also keenly aware of the many challenges and opportunities in patent protection that resulted from the America Invents Act and the pathway created for biosimilars, along with the associated guidance from federal agencies.

We have advised large pharmaceutical companies and the federal government with regard to licensing and the analysis of patent portfolios for acquisitions and/or product development. Additionally, our biologics/pharmaceutical team has experience with adversarial patent proceedings before courts and patent offices in the United States and Europe.

Our technical backgrounds as trained chemists, biochemists and molecular biologists allow us to partner closely with our clients so that we can easily grasp their research goals and biomedical innovations and provide streamlined, effective patent counsel. For example, our attorneys have conducted research in the fields of neurobiology, immunology, cancer, endocrinology, pharmacokinetics, cardiovascular and renal pharmacology, and genetics (including transgenics) in academic and industrial laboratories.

Representative Life Science Experience:

  • Patenting novel compounds, polymorphs, clinical indications, methods of manufacture, and methods of use.
  • Patenting biologics, such as therapeutic antibodies, peptides, silencing and anti-sense RNAs, and adult stem cells.
  • Patenting diagnostics and prognostic markers.
  • Advising clients on patent issues and licensing collaboration with numerous deals with a potential value to the licensee in excess of $1 billion.
  • Conducting due diligence on patent issues for strategic acquisitions and mergers.
  • Providing strategic analysis of IP landscapes and specific patents for various disease states, including cancer, inflammatory disorders, neurodegenerative disorders, cardiovascular disorders, neuropathic and visceral pain, viral infection and metabolic diseases.
  • Advising clients on structuring patent portfolios to defend against new challenges presented by a changing legal landscape.

Note: You are using an out-of-date version of Internet Explorer that may not work with some elements of the site. Click to upgrade here.